Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-049872

Chief Medical Officer sold 2,083 shares at $36.17 ($75,342)

  • Chief Medical Officer acquired 2,083 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BALDO LANCE Chief Medical Officer 2020-09-08 Option exercise +2,083 $7.80 $16,247 2,083 D
BALDO LANCE Chief Medical Officer 2020-09-08 Sale −2,083 $36.17 $75,342 0 D
Derivatives
BALDO LANCE Chief Medical Officer 2020-09-08 Option exercise · Stock Option (Right to Buy) −2,083 429,167 D
Open-market sales · 2,083 sh · avg $36.17 · $75,342
Loading xslF345X03/doc4.xml…